Article
Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.
Oncotarget - 19 Jan 2016
Xiao Haowen, Wang Li-Mengmeng, Luo Yi, Lai Xiaoyu, Li Caihua, Shi Jimin, Tan Yamin, Fu Shan, Wang Yebo, Zhu Ni, He Jingsong, Zheng Weiyan, Yu Xiaohong, Cai Zhen, Huang He
Abstract excerpt
Although steady improvements to chemotherapeutic treatments has helped cure 80% of childhood acute lymphoblastic leukemia (ALL) cases, chemotherapy has proven to be less effective in treating the majority of adult patients, leaving allogeneic hematopoietic stem cell transplantation (allo-HSCT) as the primary adult treatment option. Nevertheless relapse are the leading cause of death following allo-HSCT. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
